atherosclerotic lesions_Tg(Ins2-Nos2)40Okam/0,Tg(Kdr-AGER)102Hyam/0

http://metadb.riken.jp/0005338IC57BL6JCBAJCD1DBA2TgIns2Nos240Okam0TgKdrAGER102Hyam0TgIns2Nos240OkamTgKdrAGER102Hyam

atherosclerotic lesions_Tg(Ins2-Nos2)40Okam/0,Tg(Kdr-AGER)102Hyam/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 102, Hiroshi Yamamoto
  http://metadb.riken.jp/db/mgi_rdf/MGI:3696981
• transgene insertion 40, Hiroshi Okamoto
  http://metadb.riken.jp/db/mgi_rdf/MGI:3706437

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Ins2-Nos2)40Okam/0,Tg(Kdr-AGER)102Hyam/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Ins2-Nos2)40Okam|Tg(Kdr-AGER)102Hyam

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J * CBA/J * CD-1 * DBA/2

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• atherosclerotic lesions
  http://purl.obolibrary.org/obo/MP_0005338

文献

http://purl.org/net/cito/citesAsAuthority

• Y. Yamamoto, et.al., Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice., The Journal of clinical investigation, 2001, 108
  http://rdf.ncbi.nlm.nih.gov/pubmed/11457879